Sign in

NCT07267923Completed

Investigation of the Acute Effects of Traditional and Functional IMT on Muscle Oxygenation in COPD

Investigation of the Acute Effects of Traditional and Functional Inspiratory Muscle Training on Muscle Oxygenation in Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 9 Apr 2026

Brief summary (registry, in English)

This study aims to compare the effects of functional and conventional inspiratory muscle training (IMT) on post-exercise muscle deoxygenation in individuals with Chronic Obstructive Pulmonary Disease (COPD). Participants will complete both training modalities on separate days. A 2-minute walk test (2MWT) will be performed baseline, and after each session. Muscle oxygenation (SmO₂) will be assessed using near-infrared spectroscopy . Dyspnea and fatigue will be evaluated with the Modified Borg Scale, and heart rate and oxygen saturation (SpO₂) will be measured by pulse oximetry. Measurements will be recorded before, after training and at the end of the walking test.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
17 Nov 2025
Start date
11 Nov 2025
Primary completion date
1 Jan 2026
Lead sponsor
Saglik Bilimleri Universitesi
Diseases
COPD
NCT number
NCT07267923

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 11 Nov 2025 to the primary completion date, 1 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having had a respiratory tract infection within the past month,
  • Having any disease or medical condition that prevents participation in exercise, -Having cognitive impairment (a score of \<24 on the Mini-Mental Test).

Other

  • Having a recent exacerbation or complication requiring hospitalization,

Who the study is looking for

  • Being 18 years of age or older,
  • Having a diagnosis of COPD,
  • Being in stage II-III according to the GOLD classification,
  • Being able to mobilize independently.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Gülhane Faculty of Physiotherapy and Rehabilitation
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.